Literature DB >> 8307606

Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO.

I N Bird1, J H Spragg, A Ager, N Matthews.   

Abstract

CD31 is a 130,000 MW cell-surface glycoprotein expressed on endothelial cells, polymorphonuclear leucocytes, monocytes and about 50% of peripheral blood lymphocytes, and it has been proposed that it plays a role in transendothelial migration. If it is involved in endothelial transmigration of lymphocytes then the proportion of CD31+ cells should be increased in the lymphocyte population which has crossed an endothelial monolayer. This was tested using two endothelial types, namely human umbilical vein endothelial cells (HUVEC) and rat high endothelial venule (RHEV) cells. As a control, lymphocyte CD45RA and CD45RO expression was also determined since there is a correlation between lymphocytes bearing these isoforms and different migratory patterns. Double labelling techniques showed a close correlation between CD31 and CD45RA expression. With HUVEC monolayers, the transmigrated lymphocyte population was depleted of CD31+ cells. This depletion was even more marked if the HUVEC monolayers had been stimulated with interleukin-1 beta (IL-1 beta). The migrated lymphocytes were enriched for CD31-CD45RO+ cells but depleted of CD31+CD45RA+ cells. In addition, lymphocyte populations depleted of CD31+ cells by immunopanning were also able to migrate across HUVEC monolayers. Taken together these data suggest that lymphocyte CD31 expression is not necessary for transmigration across HUVEC monolayers and, if anything, is negatively correlated with transmigration. With the second endothelial cell type, RHEV cells, there was no consistent change in the proportion of CD31+ lymphocyte in the transmigrated population, suggesting neither a positive nor a negative correlation between CD31+ expression and lymphocyte transmigration across RHEV cells. However, with both endothelial cell types, the migrated lymphocyte populations were enriched for the marker CD45RO. In conclusion, lymphocyte surface expression of CD31 is not necessary for transmigration across the endothelial cell types used in this study, but with both cell types an enrichment of CD45RO+ lymphocytes is seen in the migrated population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307606      PMCID: PMC1422238     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro.

Authors:  J Masuyama; J S Berman; W W Cruikshank; C Morimoto; D M Center
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

2.  CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation.

Authors:  Y Torimoto; D M Rothstein; N H Dang; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

3.  Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family.

Authors:  H Stockinger; W Schreiber; O Majdic; W Holter; D Maurer; W Knapp
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

4.  The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes.

Authors:  J L Zehnder; K Hirai; M Shatsky; J L McGregor; L J Levitt; L L Leung
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

5.  Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis.

Authors:  T Felzmann; S Gadd; O Majdic; D Maurer; P Petera; J Smolen; W Knapp
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

6.  Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets.

Authors:  M J Metzelaar; J Korteweg; J J Sixma; H K Nieuwenhuis
Journal:  Thromb Haemost       Date:  1991-12-02       Impact factor: 5.249

7.  Locomotor responses of human CD45 lymphocyte subsets: preferential locomotion of CD45RO+ lymphocytes in response to attractants and mitogens.

Authors:  I Newman; P C Wilkinson
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31).

Authors:  W A Muller; M E Berman; P J Newman; H M DeLisser; S M Albelda
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

9.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.

Authors:  S M Albelda; W A Muller; C A Buck; P J Newman
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

10.  CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.

Authors:  Y Tanaka; S M Albelda; K J Horgan; G A van Seventer; Y Shimizu; W Newman; J Hallam; P J Newman; C A Buck; S Shaw
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Adhesion of lymphocytes to hepatic endothelium.

Authors:  P F Lalor; D H Adams
Journal:  Mol Pathol       Date:  1999-08

2.  Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration.

Authors:  N J Borthwick; A N Akbar; L P MacCormac; M Lowdell; J L Craigen; I Hassan; J E Grundy; M Salmon; K L Yong
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  TCR stimulation drives cleavage and shedding of the ITIM receptor CD31.

Authors:  Giulia Fornasa; Emilie Groyer; Marc Clement; Jordan Dimitrov; Caroline Compain; Anh-Thu Gaston; Aditi Varthaman; Jamila Khallou-Laschet; Debra K Newman; Stéphanie Graff-Dubois; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  J Immunol       Date:  2010-04-16       Impact factor: 5.422

4.  Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 5.  Mechanisms of leukocyte transendothelial migration.

Authors:  William A Muller
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata.

Authors:  Jyrki Ivanoff; Toomas Talme; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

7.  CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo.

Authors:  Liang Ma; Kenneth C P Cheung; Madhav Kishore; Sussan Nourshargh; Claudio Mauro; Federica M Marelli-Berg
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

8.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

9.  The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function.

Authors:  Debra K Newman; Guoping Fu; Tamara Adams; Weiguo Cui; Vidhyalakshmi Arumugam; Theresa Bluemn; Matthew J Riese
Journal:  Sci Signal       Date:  2016-03-08       Impact factor: 8.192

10.  Extravasation of leukocytes in comparison to tumor cells.

Authors:  Carina Strell; Frank Entschladen
Journal:  Cell Commun Signal       Date:  2008-12-04       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.